Is a complete ORIC research report available?

No complete published report is available for ORIC Pharmaceuticals, Inc. (ORIC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · USD

$9.32

+0.32 (+3.6%)· Recorded snapshot

Market cap	966M
Net income (ttm)	-140.4M
EPS (ttm)	-$1.35
Shares out	103.7M
Volume	1,172,864
Beta	0.98

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -140.4M
EPS (ttm): -$1.35
Market cap: 966M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001796280
Company name	ORIC Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	68622P109
Earnings date	2026-11-12
Earnings time	amc
Employees	111
Employees change	-17
Employees growth	-13.28%
Enterprise value	$707.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-04-24
Is primary listing	Yes
Is SPAC	No
ISIN number	US68622P1093
Last 10-K release date	2026-02-23
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$966M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$9.32
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ORIC
U.S. state	California
Website	https://www.oricpharma.com

Metric

Value

Amount currency

USD

CIK code

0001796280

Company name

ORIC Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

68622P109

Earnings date

2026-11-12

Earnings time

amc

Employees

111

Employees change

-17

Employees growth

-13.28%

Enterprise value

$707.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-04-24

Is primary listing

Yes

Is SPAC

ISIN number

US68622P1093

Last 10-K release date

2026-02-23

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$966M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$9.32

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ORIC

U.S. state

California

Website

https://www.oricpharma.com

Metric	Value
Earnings yield	-14.5%
FCF / EV yield	-16.58%
FCF yield	-11.99%
P/B ratio	2.45x
Price / tangible book value	2.46x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-14.5%

FCF / EV yield

-16.58%

FCF yield

-11.99%

P/B ratio

2.45x

Price / tangible book value

2.46x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-1.3M
ROA	-25.97%
ROA (5Y)	-24.85%
ROCE	-40.67%
ROE	-39.8%
ROE (5Y)	-41.01%
ROIC	-27.13%

Metric

Value

Profit per employee

$-1.3M

ROA

-25.97%

ROA (5Y)

-24.85%

ROCE

-40.67%

ROE

-39.8%

ROE (5Y)

-41.01%

ROIC

-27.13%

Metric	Value
EPS growth quarters	4
EPS growth years	3
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-620,000
Depreciation and amortization	$1.1M
EBIT	$-156.1M
EBITDA	$-155M
EPS	$-1.35
FCF per share	$-1.08
Financing cash flow	$172.9M
Free cash flow	$-112.3M
Free cash flow minus SBC	$-138.2M
Investing cash flow	$-99.7M
Net cash flow	$-38.4M
Net income	$-140.4M
Operating cash flow minus SBC	$-137.5M
Operating income	$-156.1M
Stock-based compensation	$25.9M

Metric

Value

Capital expenditures

$-620,000

Depreciation and amortization

$1.1M

EBIT

$-156.1M

EBITDA

$-155M

EPS

$-1.35

FCF per share

$-1.08

Financing cash flow

$172.9M

Free cash flow

$-112.3M

Free cash flow minus SBC

$-138.2M

Investing cash flow

$-99.7M

Net cash flow

$-38.4M

Net income

$-140.4M

Operating cash flow minus SBC

$-137.5M

Operating income

$-156.1M

Stock-based compensation

$25.9M

Metric	Value
Book value per share	$3.68
Debt / equity	0.02
Long-term assets	$131M
Long-term liabilities	$2.7M
Net cash (debt)	$258.8M
Net cash / market cap	27.65%
Net cash growth	-5.71%
Net debt / equity	-0.68
Piotroski F-Score	1
Property, plant and equipment	$2.2M
Shareholders' equity	$381.3M
Tangible book value	$381.3M
Tangible book value per share	$3.68
Total assets	$404.7M
Total cash	$264.8M
Total debt	$6M
Total liabilities	$23.4M
WACC	9.58%

Metric

Value

Book value per share

$3.68

Debt / equity

0.02

Long-term assets

$131M

Long-term liabilities

$2.7M

Net cash (debt)

$258.8M

Net cash / market cap

27.65%

Net cash growth

-5.71%

Net debt / equity

-0.68

Piotroski F-Score

Property, plant and equipment

$2.2M

Shareholders' equity

$381.3M

Tangible book value

$381.3M

Tangible book value per share

$3.68

Total assets

$404.7M

Total cash

$264.8M

Total debt

$6M

Total liabilities

$23.4M

WACC

9.58%

Metric	Value
Current assets	$273.7M
Current liabilities	$20.8M
Current ratio	13.19
Net working capital	$-8.5M
Quick ratio	12.76
Working capital	$252.9M

Metric

Value

Current assets

$273.7M

Current liabilities

$20.8M

Current ratio

13.19

Net working capital

$-8.5M

Quick ratio

12.76

Working capital

$252.9M

Metric	Value
Buyback yield / dilution	-43.06%
Dividend yield	0%
Shareholder yield	-43.06%

Metric

Value

Buyback yield / dilution

-43.06%

Dividend yield

Shareholder yield

-43.06%

Metric	Value
150-day SMA	$10.98
1D price change	3.56%
1M price change	-30.78%
1M total return	-30.78%
1W price change	-33.89%
1W total return	-33.89%
1Y price change	-32.01%
1Y return CAGR	-32.03%
1Y total return	-32.01%
20-day SMA	$11.96
200-day SMA	$11.16
3M price change	-24.21%
3M total return	-24.21%
3Y price change	45.06%
3Y return CAGR	13.2%
3Y total return	45.06%
50-day SMA	$12.66
50-day SMA vs 200-day SMA	50over200
52-week high	$14.68
52-week high date	2026-08-19
52-week low	$7.23
52-week low date	2026-04-02
5Y price change	-38.57%
5Y return CAGR	-9.29%
5Y total return	-38.57%
6M price change	-10.6%
6M total return	-10.6%
All-time high	$40.81
All-time high date	2020-12-18
All-time low	$2.36
All-time low date	2022-11-04
Average true range (ATR)	$1.00
Average volume	1.9M
Beta (1Y)	0.85
Beta (2Y)	1.07
Beta (5Y)	0.98
Change from 52-week high	-36.51%
Change from 52-week low	28.91%
Change from all-time high	-77.68%
Change from all-time low	286.02%
Change from open	4.95%
Day's gap	-1.33%
Dollar volume	$10.9M
High price	$9.32
Low price	$8.65
Monthly RSI	47.03
Open price	$8.88
Position in 52-week range	100%
Previous close	$9.00
Price vs 150-day SMA	-17.06%
Price vs 20-day SMA	-23.85%
Price vs 200-day SMA	-18.33%
Price vs 50-day SMA	-28.06%
Relative volume	0.63
Return from IPO open	-65.27%
Return from IPO price	-43.56%
RSI	30.26
Sharpe ratio	0.01
Sharpe ratio (3Y)	0.58
Sharpe ratio (5Y)	0.28
Sortino ratio	0.07
Sortino ratio (3Y)	0.94
Sortino ratio (5Y)	0.52
Volume	1.2M
Weekly RSI	40.43
YTD price change	11.37%
YTD total return	11.37%

Metric

Value

150-day SMA

$10.98

1D price change

3.56%

1M price change

-30.78%

1M total return

-30.78%

1W price change

-33.89%

1W total return

-33.89%

1Y price change

-32.01%

1Y return CAGR

-32.03%

1Y total return

-32.01%

20-day SMA

$11.96

200-day SMA

$11.16

3M price change

-24.21%

3M total return

-24.21%

3Y price change

45.06%

3Y return CAGR

13.2%

3Y total return

45.06%

50-day SMA

$12.66

50-day SMA vs 200-day SMA

50over200

52-week high

$14.68

52-week high date

2026-08-19

52-week low

$7.23

52-week low date

2026-04-02

5Y price change

-38.57%

5Y return CAGR

-9.29%

5Y total return

-38.57%

6M price change

-10.6%

6M total return

-10.6%

All-time high

$40.81

All-time high date

2020-12-18

All-time low

$2.36

All-time low date

2022-11-04

Average true range (ATR)

$1.00

Average volume

1.9M

Beta (1Y)

0.85

Beta (2Y)

1.07

Beta (5Y)

0.98

Change from 52-week high

-36.51%

Change from 52-week low

28.91%

Change from all-time high

-77.68%

Change from all-time low

286.02%

Change from open

4.95%

Day's gap

-1.33%

Dollar volume

$10.9M

High price

$9.32

Low price

$8.65

Monthly RSI

47.03

Open price

$8.88

Position in 52-week range

100%

Previous close

$9.00

Price vs 150-day SMA

-17.06%

Price vs 20-day SMA

-23.85%

Price vs 200-day SMA

-18.33%

Price vs 50-day SMA

-28.06%

Relative volume

0.63

Return from IPO open

-65.27%

Return from IPO price

-43.56%

RSI

30.26

Sharpe ratio

0.01

Sharpe ratio (3Y)

0.58

Sharpe ratio (5Y)

0.28

Sortino ratio

0.07

Sortino ratio (3Y)

0.94

Sortino ratio (5Y)

0.52

Volume

1.2M

Weekly RSI

40.43

YTD price change

11.37%

YTD total return

11.37%

Metric	Value
Float	88.7M
Float percentage	85.56%
Shares change (QoQ)	2.41%
Shares change (YoY)	43.06%
Shares held by insiders	1.04%
Shares held by institutions	106.93%
Shares outstanding	103.7M
Short % of float	18.4%
Short % of shares	15.74%
Short ratio	11.2 days

Metric

Value

Float

88.7M

Float percentage

85.56%

Shares change (QoQ)

2.41%

Shares change (YoY)

43.06%

Shares held by insiders

1.04%

Shares held by institutions

106.93%

Shares outstanding

103.7M

Short % of float

18.4%

Short % of shares

15.74%

Short ratio

11.2 days

ORIC Pharmaceuticals, Inc. (ORIC)

Price

Financial snapshot

Fair-value bridge

Latest news · ORIC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ORIC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ORIC

Frequently asked questions